Cervical Cancer Vaccine Benefit Lasts
Cervical Cancer Vaccine Benefit Lasts
April 17, 2007 (Los Angeles) -- Two vaccines for preventing cervical cancer, one that is already available and another that is undergoing FDA review, continue to offer nearly 100% protection five years following administration, new research shows.
The findings come at a time when use of the vaccines is being hotly debated, with states grappling with the issue of access to a vaccine for a sexually transmitted disease.
Darron R. Brown, MD, professor of medicine, microbiology, and immunology at the Indiana University School of Medicine in Indianapolis, says the durability of the protection is an important issue.
"Right now, the data suggest strong sustainability with either vaccine. We don't know if a booster will be needed, but from what we're seeing, I think the vaccines will provide protection for a lifetime," he tells WebMD.
The vaccines were discussed at the annual meeting of the American Association for Cancer Research.
Essential Screening Tests Every Woman Needs
The findings come at a time when use of the vaccines is being hotly debated, with states grappling with the issue of access to a vaccine for a sexually transmitted disease.
Darron R. Brown, MD, professor of medicine, microbiology, and immunology at the Indiana University School of Medicine in Indianapolis, says the durability of the protection is an important issue.
"Right now, the data suggest strong sustainability with either vaccine. We don't know if a booster will be needed, but from what we're seeing, I think the vaccines will provide protection for a lifetime," he tells WebMD.
The vaccines were discussed at the annual meeting of the American Association for Cancer Research.
Essential Screening Tests Every Woman Needs
